Amgen, U.S. states in $71 mln settlement over drug marketing
August 18, 2015 at 12:25 PM EDT
Aug 18 (Reuters) - Amgen Inc has reached a $71 million settlement with 48 U.S. states and the District of Columbia to resolve claims that it promoted two of its most popular drugs, Aranesp and Enbrel, for off-label uses.
